JPRN-UMIN000051260已完成Unknown
A placebo-controlled, double-blind, randomized, comparative superiority trial concerning subjective physical symptoms effected by taking lactic acid bacteria in healthy adults. - A placebo-controlled, double-blind, randomized, comparative superiority trial concerning subjective physical symptoms effected by taking lactic acid bacteria in healthy adults.
IMEQRD Co., Ltd0 个研究点目标入组 200 人开始时间: 2023年7月14日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Those who are undergoing treatment for malignant tumor, respiratory disease, liver, kidney, heart, lung, digestive system, blood, endocrine system, metabolic system, etc., or those who have a serious history of these. 2.Those who have or have a history of drug allergies or serious food allergies. 3.Those who are pregnant or breastfeeding, or willing to be pregnant during the trial period. 4.Those who have autoimmune diseases. 5.Alcohol drinking over 40g/day (nearly equal to 2 medium-sized beer bottles) more than 3 days per a week. 6.Those who use drugs that are thought to affect immune function including antiallergic drugs and antibiotics, or who regularly use foods containing specific bifidobacteria, lactic acid bacteria, etc. However, those who can stop after obtaining consent can participate. 7.Those who have participated in other clinical trials within 4 weeks before the date of the consent obtained, or those who plan to participate during the trial period. 8.Those who have collected 400 mL or more of blood within 4 weeks before the consent obtained, or 200 mL or more of blood was collected before the date of pre-intake examination after the consent obtained. 9.Those who have been vaccinated against infectious diseases such as influenza and novel coronavirus within 4 weeks before the day of the pre-ingestion inspection. 10.Those who are judged by the investigator to be unsuitable as a study participant based on the results of study participant background, physical findings, medical examination, physical examination, clinical examination, etc.
研究者
相似试验
已完成
Unknown
A placebo-controlled, double-blind, randomized, comparative trial concerning body composition effected by continuously taking test food in healthy adults with mildly obese.Healthy adultsJPRN-UMIN000052822utrione Co., Ltd80
已完成
不适用
A double-blind, randomized, placebo-controlled, combined single and multiple ascending dose study to investigate the safety, tolerability and pharmacokinetic profile of AB928 in healthy volunteers.NL-OMON46373Arcus Biosciences, Inc.86
招募中
不适用
STUDY to understand the effect and tolerance of Experimental product in patient with UPPER RESPIRATORY TRACT INFECTIONS (URTI)CTRI/2021/09/036807Vedic Lifesciences Pvt Ltd
进行中（未招募）
1 期
A double-blind, placebo controlled, randomized, comparative, mono-centre trial to assess the effects on the androgen metabolism and its effects on biochemical parameters, mood, fat, muscle and bone of continuous supplementation with dehydroepiandrosterone in women using a monophasic contraception containing drospirenone and ethinylestradiol - AMUSABiochemical disturbances (androgens, lipids, bone markers, endocrine) and mood disturbances caused by the use of Oral Contraception (OC).EUCTR2007-003788-28-BEPantarhei Bioscience B.V.99
进行中（未招募）
1 期
A double-blind, placebo controlled, randomized, comparative, mono-centre trial to assess the impact of a monthly administration of 50.000 IU of Vitamin D during 6 months on Vitamin D level in healthy young adult volunteers. - D-plusEUCTR2010-022454-17-BEniversity of Liège- Dpt de Médecine Générale